시장보고서
상품코드
1208549

치주질환 치료 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2022-2031년)

Periodontal Treatment Market (Treatment Type: Non-surgical Treatment and Surgical Treatment) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 130 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 치주질환(Periodontal) 치료 시장에 대해 조사했으며, 시장 개요, 2022-2031년 예측, 치료 유형별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계의 치주질환 치료 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계의 치주질환 치료 시장 분석과 예측, 2017-2031년

제5장 주요 인사이트

제6장 세계의 치주질환 치료 시장 분석과 예측, 치료 유형별

  • 서론과 정의
  • 주요 조사 결과/개발
  • 시장 매출 예측, 치료 유형별, 2017-2031년
    • 비외과적 치료
    • 외과적 치료
  • 시장의 매력 분석, 치료 유형별

제7장 세계의 치주질환 치료 시장 분석과 예측, 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/개발
  • 시장 매출 예측, 최종사용자별, 2017-2031년
    • 병원
    • 치과의원
    • 기타
  • 시장의 매력 분석, 최종사용자별

제8장 세계의 치주질환 치료 시장 분석과 예측, 지역별

  • 주요 조사 결과
  • 시장 매출 예측, 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석, 지역별

제9장 북미의 치주질환 치료 시장 분석과 예측

제10장 유럽의 치주질환 치료 시장 분석과 예측

제11장 아시아태평양의 치주질환 치료 시장 분석과 예측

제12장 라틴아메리카의 치주질환 치료 시장 분석과 예측

제13장 중동 및 아프리카의 치주질환 치료 시장 분석과 예측

제14장 경쟁 구도

  • 시장 참여 기업 - 경쟁 매트릭스
  • 시장 점유율/순위 분석, 기업별,(2021년)
  • 기업 개요
    • 3M
    • AMD Lasers, Inc.
    • ASA Dental SpA
    • Biolase, Inc.
    • Carl Martin GmbH
    • Danaher
    • Dentsply Sirona
    • Deppeler SA
    • Karl Schumacher
    • Medtronic
    • Novartis AG
    • Pfizer, Inc.
    • Planmeca Oy
    • Steris-Hu-Friedy
    • Straumann AG
LSH 23.02.23

The report provides revenue of the global periodontal treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global periodontal treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the periodontal treatment market.

The report delves into the competitive landscape of the global periodontal treatment market. Key players operating in the global periodontal treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global periodontal treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Periodontal Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate globally with key countries
  • 5.2. Key Industry Events (mergers & acquisitions, product launches, partnerships, etc.)
  • 5.3. Overview on types and causes of Periodontal Disease
  • 5.4. Outlook of Major Products used in Surgical and Non-surgical Treatment
  • 5.5. Covid-19 Pandemic Impact on the Industry

6. Global Periodontal Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2017-2031
    • 6.3.1. Non-surgical Treatment
      • 6.3.1.1. Scaling & Root Planning
      • 6.3.1.2. Antibiotics
        • 6.3.1.2.1. Systemic Antibiotics
        • 6.3.1.2.2. Local Antibiotics
    • 6.3.2. Surgical Treatment
      • 6.3.2.1. Pocket Reduction Surgery
      • 6.3.2.2. Soft Tissue Grafts
      • 6.3.2.3. Bone Grafts
      • 6.3.2.4. Others
  • 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Periodontal Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Dental Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Periodontal Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Periodontal Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 9.2.1. Non-surgical Treatment
      • 9.2.1.1. Scaling & Root Planning
      • 9.2.1.2. Antibiotics
        • 9.2.1.2.1. Systemic Antibiotics
        • 9.2.1.2.2. Local Antibiotics
    • 9.2.2. Surgical Treatment
      • 9.2.2.1. Pocket Reduction Surgery
      • 9.2.2.2. Soft Tissue Grafts
      • 9.2.2.3. Bone Grafts
      • 9.2.2.4. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Dental Clinics
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Treatment Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Periodontal Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 10.2.1. Non-surgical Treatment
      • 10.2.1.1. Scaling & Root Planning
      • 10.2.1.2. Antibiotics
        • 10.2.1.2.1. Systemic Antibiotics
        • 10.2.1.2.2. Local Antibiotics
    • 10.2.2. Surgical Treatment
      • 10.2.2.1. Pocket Reduction Surgery
      • 10.2.2.2. Soft Tissue Grafts
      • 10.2.2.3. Bone Grafts
      • 10.2.2.4. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Dental Clinics
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Treatment Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Periodontal Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 11.2.1. Non-surgical Treatment
      • 11.2.1.1. Scaling & Root Planning
      • 11.2.1.2. Antibiotics
        • 11.2.1.2.1. Systemic Antibiotics
        • 11.2.1.2.2. Local Antibiotics
    • 11.2.2. Surgical Treatment
      • 11.2.2.1. Pocket Reduction Surgery
      • 11.2.2.2. Soft Tissue Grafts
      • 11.2.2.3. Bone Grafts
      • 11.2.2.4. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Dental Clinics
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Treatment Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Periodontal Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 12.2.1. Non-surgical Treatment
      • 12.2.1.1. Scaling & Root Planning
      • 12.2.1.2. Antibiotics
        • 12.2.1.2.1. Systemic Antibiotics
        • 12.2.1.2.2. Local Antibiotics
    • 12.2.2. Surgical Treatment
      • 12.2.2.1. Pocket Reduction Surgery
      • 12.2.2.2. Soft Tissue Grafts
      • 12.2.2.3. Bone Grafts
      • 12.2.2.4. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Dental Clinics
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Treatment Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Periodontal Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 13.2.1. Non-surgical Treatment
      • 13.2.1.1. Scaling & Root Planning
      • 13.2.1.2. Antibiotics
        • 13.2.1.2.1. Systemic Antibiotics
        • 13.2.1.2.2. Local Antibiotics
    • 13.2.2. Surgical Treatment
      • 13.2.2.1. Pocket Reduction Surgery
      • 13.2.2.2. Soft Tissue Grafts
      • 13.2.2.3. Bone Grafts
      • 13.2.2.4. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Dental Clinics
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Treatment Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share/Ranking Analysis, by Company, (2021)
  • 14.3. Company Profiles
    • 14.3.1. 3M
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. AMD Lasers, Inc.
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. ASA Dental S.p.A.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Biolase, Inc.
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Carl Martin GmbH
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Danaher
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. Dentsply Sirona
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Deppeler SA
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. Karl Schumacher
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Medtronic
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview
    • 14.3.11. Novartis AG
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Strategic Overview
    • 14.3.12. Pfizer, Inc.
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview
    • 14.3.13. Planmeca Oy
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. SWOT Analysis
      • 14.3.13.4. Strategic Overview
    • 14.3.14. Steris-Hu-Friedy
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. SWOT Analysis
      • 14.3.14.4. Strategic Overview
    • 14.3.15. Straumann AG
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. SWOT Analysis
      • 14.3.15.4. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제